淋巴瘤
基因重排
B细胞
B细胞淋巴瘤
免疫球蛋白重链
生物
癌症研究
淋巴系统
免疫组织化学
病理
抗体
基因
免疫学
医学
遗传学
出处
期刊:PubMed
[National Institutes of Health]
日期:2022-08-01
卷期号:30 (4): 1291-1295
被引量:1
标识
DOI:10.19746/j.cnki.issn.1009-2137.2022.04.052
摘要
B-cell lymphoma is the most common malignant lymphoma, and its incidence is increasing year by year. Some types are often indistinguishable from the reactive lesions through morphology combined with immunohistochemistry, so other auxiliary diagnostic methods are urgently needed. Since B-cell lymphoma is caused by malignant transformation of IGH rearranged B cells, the molecular characteristics of rearranged B cells can be used as an important reference for differentiating benign and malignant proliferations of lymphatic tissues. With the development of molecular biology technology, the detection of clonal rearrangement of IGH plays an important role in the diagnosis, efficacy evaluation and prognosis evaluation of lymphoma. This paper focuses on the molecular characteristics and clinical significance of clonal rearrangement of IGH in B-cell lymphoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI